Although the medical literature abounds with promises that the limited-acting barbiturates are remarkable for making slumber while the intermediate-performing compounds are simpler in maintaining rest, managed experiments have failed to display these differential effects. As a result, as snooze medications, the barbiturates are of minimal worth pas